- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 44.71M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 41.42M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 38.76M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $27.76M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $40.7M |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $3.21M |
| Capex | Q1 2026 · Mar 31, 2026 | $2.03M |
| Capex | Q1 2026 · Mar 31, 2025 | $108K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $27.33M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $9.95M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $375.36M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $407.6M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $313.45M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2024 | $363.86M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $842.78M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $858.93M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $739.61M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $765.17M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $6.38B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $6.15B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $7.23B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $7.01B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.36 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.33 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.37 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.33 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $3.54M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $1.38M |
| Net Income | Q1 2026 · Mar 31, 2026 | $14.98M |
| Net Income | Q1 2026 · Mar 31, 2025 | $12.66M |